-- U.S. RESEARCH ROUNDUP-Contrafect Corp, Global Payments 
-- 
-- Mon Oct 06, 2014 04:16AM EDT
-- None



Oct 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Contrafect Corp and Global Payments, on Monday.

HIGHLIGHTS * Contrafect Corp <CFRX.O>: Roth starts with buy; price target $14  * Global Payments Inc <GPN.N>: Morgan Stanley raises to equal weight from underweight  Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.   * Avago Technologies <AVGO.O>: Canaccord Genuity raises target to $97 from $95; rating buy * Centene Corp <CNC.N>: Susquehanna raises price target to $105 from $100; rating positive  * CME Group Inc <CME.O>: Jefferies raises price target to $93; rating buy  * Contrafect Corp <CFRX.O>: Roth starts with buy; price target $14  * Covance Inc <CVD.N>: Sterne Agee cuts price target to $93 from $97; rating buy  * Encana Corporation <ECA.N>: NBF cuts price target to $28 from $29; rating outperform  * Global Payments Inc <GPN.N>: Morgan Stanley raises to equal weight from underweight * Global Payments Inc <GPN.N>: Morgan Stanley raises price target to $74 from $66  * Iamgold Corp <IAG.N>: Roth raises price target to $5.50 from $5.25; rating buy  * Liberty Property TrUST <LPT.N>: JP Morgan cuts target to $38 from $39; rating neutral  * Skyworks Solutions <SWKS.O>: Canaccord Genuity raises target to $64 from $62; rating buy